(Q34283036)

1 August 2017

title

Anti-angiogenic treatment strategies for the therapy of endometriosis (English)

1 reference

1 August 2017

1 reference

angiogenesis inhibitor

1 reference

M W Laschke

1

1 reference

1 August 2017

M D Menger

series ordinal

2

1 reference

1 August 2017

publication date

19 June 2012

1 reference

Human Reproduction Update

1 August 2017

published in

1 reference

1 August 2017

volume

18

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

682-702

1 reference

Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Quinagolide--a valuable treatment option for hyperprolactinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Angiogenesis and antiangiogenic therapy in endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Endostatin inhibits the growth of endometriotic lesions but does not affect fertility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

An orally delivered small-molecule formulation with antiangiogenic and anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Peroxisome proliferator-activated receptors and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Pharmacological strategies for lowering LDL cholesterol: statins and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Simvastatin protects against the development of endometriosis in a nude mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Sirolimus--challenging current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Cabergoline for suppression of puerperal lactation in a prevention of mother-to-child HIV-transmission programme in rural Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Endometriosis and infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Statins inhibit monocyte chemotactic protein 1 expression in endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Managing endometriosis. Strategies to minimize pain and damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Molecular mechanisms and clinical applications of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Expression of cyclooxygenase-2 in eutopic endometrium and ovarian endometriotic tissue in women with severe endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Pleiotrophin (PTN) and midkine (MK) mRNA expression in eutopic and ectopic endometrium in advanced stage endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Learning to take charge: women's experiences of living with endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Effect of peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on the induction of endometriosis in an experimental rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Experimental stroke protection induced by 4-hydroxybenzyl alcohol is cancelled by bacitracin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Vascular endothelial growth factor (VEGF) in endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Xanthohumol feeding does not impair organ function and homoeostasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions--old answers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The recurrence of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Protein kinase CK2 is a regulator of angiogenesis in endometriotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Angiopoietins: a link between angiogenesis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The coxibs, selective inhibitors of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Fighting cancer by attacking its blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The endometrium versus embryonic quality in endometriosis-related infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Advances in the treatment of prolactinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The impact of endometriosis on work and social participation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Vascular development in endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Recurrence of endometriosis and its control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Angiogenesis: a new theory for endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Antiangiogenic agents are effective inhibitors of endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Angiopoietin-1, angiopoietin-2 and Tie-2 expression in eutopic endometrium in advanced endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Mechanism of phytoestrogen puerarin-mediated cytoprotection following oxidative injury: estrogen receptor-dependent up-regulation of PI3K/Akt and HO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Fibrosis and smooth muscle metaplasia in rectovaginal endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Disruption of the female reproductive system by the phytoestrogen genistein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Mechanisms of adverse effects of anti-VEGF therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Peroxisome-proliferator activator receptor-gamma activation decreases attachment of endometrial cells to peritoneal mesothelial cells in an in vitro model of the early endometriotic lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

TNP-470: an angiogenesis inhibitor in clinical development for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Dose-finding study of the multitargeted tyrosine kinase inhibitor SU6668 in patients with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Fibrates, glitazones, and peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

In vivo analysis of angiogenesis in endometriosis-like lesions by intravital fluorescence microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Genistein does not affect vascularization and blood perfusion of endometriotic lesions and ovarian follicles in dorsal skinfold chambers of Syrian golden hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Endothelial progenitor cells contribute to the vascularization of endometriotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Vasculogenesis: a new piece of the endometriosis puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

In vitro and in vivo evaluation of the anti-angiogenic actions of 4-hydroxybenzyl alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Vascular endothelial growth factor and vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Peroxisome proliferator-activated receptor-(gamma) receptor ligand partially prevents the development of endometrial explants in baboons: a prospective, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Effect of monocyte chemoattractant protein-1 and estradiol on the secretion of vascular endothelial growth factor in endometrial stromal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Puerarin protects rat kidney from lead-induced apoptosis by modulating the PI3K/Akt/eNOS pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Vascular endothelial growth factor and endometriotic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Evaluation of the effect of pentoxifylline on white blood cell count in serum and peritoneal fluid in female rats with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Thiazolidinediones as therapy for endometriosis: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Regulatory expression of lipoxin A4 receptor in physiologically estrus cycle and pathologically endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Dienogest, a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Antiangiogenesis therapy for endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Endogenous inhibitors of angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

New medical treatments for endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Fenofibrate causes regression of endometriotic implants: a rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

PPAR gamma represses VEGF expression in human endometrial cells: implications for uterine angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical efficacy studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Treatment of endometriosis with a VEGF-targeted conditionally replicative adenovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Endogenous inhibitors of angiogenesis: a historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Pregnancy outcome after cabergoline treatment in early weeks of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Pregnancy outcome after treatment with the ergot derivative, cabergoline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Lipoxin and aspirin-triggered lipoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Xanthohumol inhibits growth and vascularization of developing endometriotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Dopamine agonists and the risk of cardiac-valve regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Angiostatin and endostatin: endogenous inhibitors of tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Endometriosis: cost estimates and methodological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

New progestagens for contraceptive use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Genotoxicity of phytoestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Angiogenic factors in endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Mechanistic and therapeutic implications of angiogenesis in endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The safety of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The role of COX-2 in intestinal inflammation and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Puerarin suppresses invasion and vascularization of endometriosis tissue stimulated by 17β-estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study. European Multicentre Cabergoline Dose-finding Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Evolution of medical treatment for endometriosis: back to the roots?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Leuprolide acetate: a drug of diverse clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Possible mechanisms of the cancer-preventive activities of green tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

The function and mechanism of COX-2 in angiogenesis of gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Genistein causes regression of endometriotic implants in the rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Gastrodia elata blume and an active component, p-hydroxybenzyl alcohol reduce focal ischemic brain injury through antioxidant related gene expressions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

Phytoestrogen biological actions on Mammalian reproductive system and cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

21 January 2018

The targets of curcumin.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS026

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMS026

1 reference

1 August 2017

1 reference